Register for Zoom In On Dementia & Alzheimer’s
Register for Zoom In On Dementia & Alzheimer’s
TITLE
Is It Alzheimer’s? Recognizing Early Signs & Symptoms
DATE
Thursday, March 26, 2026
TIME
1 pm ET (please adjust for your time zone)
SPEAKER(S)
Sharon Cohen, MD FRCPC
Detecting subtle changes in cognition can be unsettling, but recognition of what may be causing those changes can lead to critical early diagnosis–or even ruling out Alzheimer’s altogether. Behavioral neurologist Dr. Sharon Cohen explains the early signs and symptoms of Alzheimer’s disease, medical conditions that can mimic dementia, and how to start a conversation with your doctor.
Watch Past Episodes
Understanding Your APOE Status: Genetics and Alzheimer’s Risk
About 25% of people carry one copy of the APOE4 gene, the strongest genetic risk factor for developing Alzheimer’s. Dr. Eric M. Reiman explains what genetic testing can—and cannot—tell you, including why APOE4 signals increased risk but does not mean a definite Alzheimer’s diagnosis.
Leqembi and Kisunla: Your Questions Answered
A leading neurologist answers your most common questions about what Leqembi and Kisunla can realistically do, including effectiveness, safety, eligibility, infusion logistics, cost, and access.
The AHEAD Study: Can Alzheimer’s Be Prevented or Slowed Before Symptoms Begin?
Join Dr. Joshua Grill as he shares details about the AHEAD Study.
The Next Generation of Alzheimer’s Treatments
Join behavioral neurologist Dr. Marwan Sabbagh for an in-depth discussion about emerging Alzheimer’s therapeutics now in late-stage clinical development.
The Gut Microbiome and Alzheimer’s Disease: Understanding the Connection
Join Dr. Beau Ances of Washington University in St. Louis to learn about the emerging science linking gut health and brain health.
U.S. POINTER Study Update: Lifestyle Program Significantly Improves Cognition in Older Adults
Can everyday lifestyle choices really protect your memory? Dr. Laura Baker, professor at Wake Forest University School of Medicine, will share results from the groundbreaking U.S. POINTER trial—the largest study of its kind to test how lifestyle changes impact brain health.
Non-Invasive Light and Sound Stimulation Therapy in Alzheimer’s: Update on HOPE Study
Can light and sound help slow Alzheimer’s? Join Christian Howell, CEO of Cognito Therapeutics, as he shares the latest on the HOPE Study. Discover how non-invasive 40 Hz light and sound stimulation may protect memory, thinking, and daily function—and what’s next for this promising technology.
Can GLP-1 Weight Loss Drugs Treat Alzheimer’s?
Recent research suggests that GLP 1 analogs—a class of drugs used to control blood sugar—may also protect brain health, improve memory, and slow neurodegeneration.
Can Brain Tissue Be Regenerated? Inside the ReGenBrain Trial
Can brain tissue be regenerated? Join Roberta Diaz Brinton, PhD, Director of the Center for Innovation in Brain Science at the University of Arizona, to learn about the ReGenBRAIN clinical trial.
Zoom In on Dementia & Alzheimer’s is supported in part through sponsorships from:
